GILD
$92.38
Revenue | $7545Mn |
Net Profits | $1253Mn |
Net Profit Margins | 16.61% |
Gilead Sciences Inc.’s revenue jumped 7.02% since last year same period to $7545Mn in the Q3 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated 8.58% jump in its revenue since last 3-months.
Gilead Sciences Inc.’s net profit fell -42.52% since last year same period to $1253Mn in the Q3 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated -22.37% fall in its net profits since last 3-months.
Gilead Sciences Inc.’s net profit margin fell -46.29% since last year same period to 16.61% in the Q3 2024. On a quarterly growth basis, Gilead Sciences Inc. has generated -28.5% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.55 |
EPS Estimate Current Year | 1.55 |
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.55 - a -3.13% fall from last quarter’s estimates.
Gilead Sciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.55.
Earning Per Share (EPS) | 2.02 |
Dividend Per Share (DPS) | 0.77 |
Gilead Sciences Inc.’s earning per share (EPS) fell -11.79% since last year same period to 2.02 in the Q3 2024. This indicates that the Gilead Sciences Inc. has generated -11.79% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Gilead Sciences Inc. declared 0.77 dividend per share during the earnings announcement for Q3 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-08 | 1.6 | 2.01 | 25.62% |
2024-11-12 | 1.55 | 2.02 | 30.32% |
2024-05-08 | -1.49 | -1.32 | 11.41% |